Definigen Company
Human iPSC, regenerative medicine, CRISPR gene editing, patients-derived cell banks.
.png)
.jpg)
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
7-4
Employees Number:
11-50
Funding Status:
N/A
Investors Number:
7
Total Funding:
£5.8M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership